Showing 861 - 880 results of 112,703 for search '(( 10 ((nm decrease) OR (we decrease)) ) OR ( 50 ((a decrease) OR (nn decrease)) ))', query time: 1.08s Refine Results
  1. 861

    Chloro Half-Sandwich Osmium(II) Complexes:  Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity by Anna F. A. Peacock (1297842)

    Published 2007
    “…Relatively little is known about the kinetics or the pharmacological potential of organometallic complexes of osmium compared to its lighter congeners, iron and ruthenium. We report the synthesis of seven new complexes, [(η<sup>6</sup>-arene)Os(NN)Cl]<sup>+</sup>, containing different bidentate nitrogen (N,N) chelators, and a dichlorido complex, [(η<sup>6</sup>-arene)Os(N)Cl<sub>2</sub>]. …”
  2. 862

    Chloro Half-Sandwich Osmium(II) Complexes:  Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity by Anna F. A. Peacock (1297842)

    Published 2007
    “…Relatively little is known about the kinetics or the pharmacological potential of organometallic complexes of osmium compared to its lighter congeners, iron and ruthenium. We report the synthesis of seven new complexes, [(η<sup>6</sup>-arene)Os(NN)Cl]<sup>+</sup>, containing different bidentate nitrogen (N,N) chelators, and a dichlorido complex, [(η<sup>6</sup>-arene)Os(N)Cl<sub>2</sub>]. …”
  3. 863

    Cardiac Contractility Structure-Activity Relationship and Ligand-Receptor Interactions; the Discovery Of Unique and Novel Molecular Switches in Myosuppressin Signaling by Megan Leander (459603)

    Published 2015
    “…Further, these motifs were present in red flour beetle, common water flea, honey bee, domestic silkworm, and termite MS-Rs. RhpMS and DrmMS decreased <i>R</i>. <i>prolixus</i> cardiac contractility dose dependently with EC<sub>50</sub> values of 140 nM and 50 nM. …”
  4. 864

    Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio by Julian Laux (13047767)

    Published 2023
    “…., tofacitinib, 0.2–0.4 μmol/kg bid) in clinical use, suggesting an efficient underlying mode of action. We hypothesized that their effectiveness is due to their ability to raise the ratio of IL-10 to TNFα. …”
  5. 865
  6. 866
  7. 867
  8. 868
  9. 869
  10. 870

    Substitution of a lysine residue at position 8 of two model 9mer H2-K<sup>b</sup> epitope precursors leads to a marked decrease of N-terminus trimming by ERAP1 <i>in vitro</i>. by Irini Evnouchidou (375919)

    Published 2013
    “…<p><i>Panels </i><i>A</i><i> and </i><i>B</i>, peptides LSIINFEKL and the variant LSIINFEAL (both at 50 µM) were incubated with 7.8 nM of ERAP1 for 1 hr at 37°C and the products analyzed by RP-HPLC. …”
  11. 871

    Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells by Tadeja Kuret (5059433)

    Published 2018
    “…<div><p>Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. …”
  12. 872

    Metabolic health is more closely associated with decrease in lung function than obesity by Hea Yon Lee (6256655)

    Published 2019
    “…</p><p>Methods</p><p>Total 10,071 participants were evaluated at the Health Promotion Center in Seoul St. …”
  13. 873
  14. 874
  15. 875
  16. 876

    Statistical details of data presented in Fig 16. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  17. 877

    Statistical details of data presented in Fig 17. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  18. 878

    Simon Nilsson’s polygon features in action. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  19. 879

    Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases by Xiao Li (107004)

    Published 2022
    “…Compared to the type I PRMT inhibitor from our previous work (DCPR049_12), ZL-28-6 showed increased potency against CARM1 and decreased activity against other type I PRMTs. Moreover, ZL-28-6 showed better antiproliferation activities toward a series of solid tumor cells than DCPR049_12, indicating its broad spectrum of anticancer activity. …”
  20. 880